| Brittanie Dannehl, | |
|
1103 Buffalo Bnd, Lexington, NE 68850-1528 | |
| (308) 324-6386 | |
| (308) 324-6913 |
| Full Name | Brittanie Dannehl |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant - Medical |
| Location | 1103 Buffalo Bnd, Lexington, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679937833 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 2006 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brittanie Dannehl, Po Box 797, Lexington, NE 68850-0797 Ph: (308) 324-6386 | Brittanie Dannehl, 1103 Buffalo Bnd, Lexington, NE 68850-1528 Ph: (308) 324-6386 |
News Archive
An interdisciplinary team from the Institute of Radiopharmaceutical Cancer Research headed by Prof. Peter Brust has won HZDR's (Helmholtz-Zentrum Dresden-Rossendorf) third Innovation Contest.
In a study published on 1st March 2005 in Nature Structural & Molecular Biology, a combined team discovered the structure of a protein known as resuscitation promoting factor (Rpf). Five versions of the Rpf protein exist in TB bacteria. The paper's unveiling of the molecular structure of Rpf could be crucial to the treatment of TB in the future.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection, known in the scientific literature as VEGF Trap-Eye, for the treatment of patients with neovascular (wet) Age-related Macular Degeneration (AMD) at a recommended dose of 2 milligrams every four weeks for the first 12 weeks, followed by 2 mg every eight weeks.
Patients with obstructive sleep apnea (OSA) may blame their daytime difficulties on simple sleepiness, but new research suggests that their brains may be to blame. Specifically, their cognitive challenges may be caused by structural deficits in gray matter, brought on by the intermittent oxygen deprivation that comes with OSA. The good news is that these deficits may be partially or fully reversible with early detection and treatment, according to Italian researchers
Lineagen, Inc., a developer of innovative genomic tests and services for the screening, evaluation and diagnosis of complex disorders and diseases including autism spectrum disorders and others, today announced that PrairieGold Venture Partners has joined Lineagen's existing institutional venture investors in a further $5 million closing of its Series A round, which completes Lineagen's $10.8 million Series A financing.
› Verified 8 days ago
Adam Dannehl, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1103 Buffalo Bnd, Lexington, NE 68850 Phone: 308-324-6386 Fax: 308-324-6913 | |
Jennifer C Hunke, Physician Assistant Medicare: Medicare Enrolled Practice Location: 1103 Buffalo Bnd, Lexington, NE 68850 Phone: 308-324-6386 Fax: 308-324-6913 | |
Roger D Wells, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1201 N Erie St, Lexington, NE 68850 Phone: 308-324-5651 | |
Katherine E. Hueftle, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1201 N Erie St, Lexington, NE 68850 Phone: 308-324-5651 Fax: 308-324-8359 | |
Sidney W Jaeger, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1103 Buffalo Bnd, Lexington, NE 68850 Phone: 308-324-6386 Fax: 308-324-6913 |